Cargando…

The Safety and Effectiveness of mRNA Vaccines Against SARS-CoV-2

The coronavirus disease 2019 (COVID-19) pandemic, caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in numerous deaths worldwide, along with devastating economic disruptions, and has posed unprecedented challenges to healthcare systems around the world. I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jamous, Yahya F, Alhomoud, Dalal A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Epidemiology/Public Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588549/ https://www.ncbi.nlm.nih.gov/pubmed/37868494 http://dx.doi.org/10.7759/cureus.45602

Ejemplares similares

Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort
por: Geisen, Ulf M, et al.
Publicado: (2021)

Development of Graves' Disease After SARS-CoV-2 mRNA Vaccination: A Case Report and Literature Review
por: Lui, David Tak Wai, et al.
Publicado: (2021)

Neutralizing antibodies against SARS-CoV-2 in Brazilian pregnant women vaccinated with one or two doses of BNT162b2 mRNA vaccine (Pfizer/Wyeth(TM))
por: da Silva, Mauro César, et al.
Publicado: (2023)

Medium-term impact of the SARS-CoV-2 mRNA vaccine against disease activity in patients with systemic lupus erythematosus
por: Yoshida, Tsuneyasu, et al.
Publicado: (2022)

The Vaccine Efficacy Against the SARS-CoV-2 Omicron: A Systemic Review and Meta-Analysis
por: Zou, Yuntao, et al.
Publicado: (2022)

Immunogenicity and safety of SARS-CoV-2 vaccine in hemodialysis patients: A systematic review and meta-analysis
por: Peiyao, Ren, et al.
Publicado: (2022)

SARS-CoV-2 mRNA Vaccine Attitudes as Expressed in U.S. FDA Public Commentary: Need for a Public-Private Partnership in a Learning Immunization System
por: Weitzman, Elissa R., et al.
Publicado: (2021)

Vaccine hesitancy for coronavirus SARS-CoV-2 in Varanasi India
por: Srivastava, Utkarsh, et al.
Publicado: (2022)

Vaccine efficacy against SARS-CoV-2 for Pfizer BioNTech, Moderna, and AstraZeneca vaccines: a systematic review
por: Reynolds, Lia, et al.
Publicado: (2023)

SARS-CoV-2 Seroprevalence in Delhi, India, During September-October 2021: A Population-Based Seroepidemiological Study
por: Sharma, Pragya, et al.
Publicado: (2022)

Trends in MERS-CoV, SARS-CoV, and SARS-CoV-2 (COVID-19) Diagnosis Strategies: A Patent Review
por: Nascimento Junior, José Adão Carvalho, et al.
Publicado: (2020)

Single-dose BNT162b2 vaccine protects against asymptomatic SARS-CoV-2 infection
por: Jones, Nick K, et al.
Publicado: (2021)

How to Deal With Vaccine Breakthrough Infection With SARS-CoV-2 Variants
por: Guo, Ying, et al.
Publicado: (2022)

Safety and immunogenicity of the third (booster) dose of inactivated and recombinant protein SARS-CoV-2 vaccine for patients with endocrine-related cancer
por: Han, Shanshan, et al.
Publicado: (2023)

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
por: Baden, Lindsey R., et al.
Publicado: (2020)

Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine
por: Zeng, Guangting
Publicado: (2022)

Essential Oil Disinfectant Efficacy Against SARS-CoV-2 Microbial Surrogates
por: Bailey, Emily S., et al.
Publicado: (2021)

Antibody levels following vaccination against SARS-CoV-2: associations with post-vaccination infection and risk factors in two UK longitudinal studies
por: Cheetham, Nathan J, et al.
Publicado: (2023)

SARS-CoV-2 Vaccination Among Incarcerated People: A Barrier to Overcome
por: Fiore, Vito, et al.
Publicado: (2021)

The SARS-CoV-2 vaccination rate and hesitation in Shanghai older adults with dementia
por: Yang, Yang, et al.
Publicado: (2023)

Seroepidemiology of SARS-CoV-2 on a partially vaccinated island in Brazil: Determinants of infection and vaccine response
por: Cerbino-Neto, José, et al.
Publicado: (2022)

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
por: Jackson, Lisa A., et al.
Publicado: (2020)

Symptomology following mRNA vaccination against SARS-CoV-2
por: Ebinger, Joseph E., et al.
Publicado: (2021)

mRNA Vaccines against SARS-CoV-2: Advantages and Caveats
por: Echaide, Miriam, et al.
Publicado: (2023)

Effectiveness of mRNA vaccines in patients with cirrhosis with rising prevalence of SARS-CoV-2 delta variant
por: John, Binu, et al.
Publicado: (2022)

Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression
por: Prendecki, Maria, et al.
Publicado: (2021)

Comparison of mRNA-1273 and BNT162b2 SARS-CoV-2 mRNA Vaccine Immunogenicity in Kidney Transplant Recipients
por: Haller, Maria C., et al.
Publicado: (2022)

Systems Thinking About SARS-CoV-2
por: Klement, Rainer Johannes
Publicado: (2020)

The Origin of Sars-CoV-2: Why It Matters
por: Vineis, Paolo, et al.
Publicado: (2021)

Immunogenicity of Inactivated SARS-CoV-2 Vaccines in Patients With Rheumatoid Arthritis: A Case Series
por: Zhao, Ting, et al.
Publicado: (2022)

Prioritizing the First Doses of SARS-CoV-2 Vaccine to Save the Elderly: The Case Study of Italy
por: Pontrelli, Giuseppe, et al.
Publicado: (2021)

Effects of vaccination, new SARS-CoV-2 variants and reinfections on post-COVID-19 complications
por: Orendáčová, Mária, et al.
Publicado: (2022)

SARS-CoV-2 (COVID-19) by the numbers
por: Bar-On, Yinon M, et al.
Publicado: (2020)

Epidemiology of SARS-CoV-2 Infection Evaluated by Immunochromatographic Rapid Testing for the Determination of IgM and IgG Against SARS-CoV-2 in a Cohort of Mask Wearing Workers in the Metal-Mechanical Sector in an Area With a High Incidence of COVID-19
por: Esposito, Susanna, et al.
Publicado: (2021)

Real-world effectiveness of COVID-19 vaccines and anti-SARS-CoV-2 monoclonal antibodies against postacute sequelae of SARS-CoV-2: analysis of a COVID-19 observational registry for a diverse US metropolitan population
por: Tannous, Jonika, et al.
Publicado: (2023)

Development of Bivalent mRNA Vaccines against SARS-CoV-2 Variants
por: Li, Jianglong, et al.
Publicado: (2022)

Effectiveness of the Fiocruz recombinant ChadOx1-nCoV19 against variants of SARS-CoV-2 in the Municipality of Botucatu-SP
por: Costa Clemens, Sue Ann, et al.
Publicado: (2022)

BNT162b2 vaccine-induced humoral and cellular responses against SARS-CoV-2 variants in systemic lupus erythematosus
por: Moyon, Quentin, et al.
Publicado: (2022)

The relationship between knowledge about the pandemic and willingness to get vaccinated against SARS-CoV-2 in medical students in Poland: A cross-sectional survey
por: Jastrzẹbska, Aleksandra, et al.
Publicado: (2022)

Effectiveness of SARS-CoV-2 vaccines against Omicron infection and severe events: a systematic review and meta-analysis of test-negative design studies
por: Song, Shangchen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_454ep47f7o14riniqjfa2hmooa